PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

47,402 stories, page 61 of 791

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07887984: Comparing Bispecific Antibody Treatment to Autologous Stem Cell Transplant for Newly Diagnosed, Standard Risk Multiple Myeloma

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07887958: Feasibility, Acceptability, and Safety of a Drug-Free Nasal Spray in Frontline Healthcare Workers

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07878039: Effects of Preoperative Virtual Reality on Surgical Fear and Anxiety in Patients

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07864649: EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-occlusive Disease

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07864402: Patient State Index at Laryngoscopy and Tracheal Intubation Conditions

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07706400: Treatment of Mandibular Overjet in Children With Maxillary Retrognathism

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07667335: Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07622342: A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07619547: Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07547631: Enlace Familiar: Supporting the Mental Health of Latino Adolescents

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07532122: Postoperative Anxiety and Depression Among Chinese Elderly Patients

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07466212: QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07446491: A Study to Evaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07287917: Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07248410: A Split-Scalp Study Evaluating the Efficacy and Safety of Fractional Laser Therapy With and Without Exosomes in the Treatment of Androgenetic Alopecia

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07222189: A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07171723: Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07169630: PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07111065: FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07097012: Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06921213: Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06589869: Effect of High-Intensity Focused Electromagnetic (HIFEM) Technology in the Treatment of SUI in Chinese Men Undergone Robotic Radical Prostatectomy

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06574165: Relationships of Affect and Neuroinflammation With Clinical Pain in Veterans With Fibromyalgia

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06486441: Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06100991: CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05968391: Acetoacetate and Acetate Metabolism in Patients With Chronic Kidney Failure.(RENO-TEP)

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05846620: Pulmonary Immune Cell-microbiome Interactions in the Healthy Lung

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05805319: Dietary Intervention for NSCLC Patients Treated With ICI

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05758077: Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05237947: Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05213572: Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04387656: NCI COVID-19 in Cancer Patients, NCCAPS Study

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04145115: A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03955172: Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03228537: Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03114865: A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02474160: Collection and Storage of Tissue and Blood Samples From Patients With Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02407509: Phase I Trial of VS-6766 Alone and in Combination With Everolimus

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02000089: The Cancer of the Pancreas Screening-5 CAPS5)Study

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01064648: Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AI-Generated Evidence in Drug Discovery: Reliability, Legal Risk & FDA Compliance

Crowell & Moring LLPOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals Signs Exclusive Deal with Arrotex for 327 Topical Gel

Small CapsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Coroner raises concerns about ambulance triage of drug overdose

The Pharmaceutical JournalOriginal source
🌍Researchnews.uci.eduTier 2 · Direct publisher

Earth system scientist Jin-Yi Yu says 2026-27 El Niño could be the strongest ever

University of California IrvineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals signs Arrotex deal for RECCE 327 in Australia and New Zealand

Yahoo Finance AustraliaOriginal source
🌍discoverynews.google.comTier 2 · Trade media

China biotech RiboX reveals first data of circular RNA therapies in people

Endpoints NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

new fda approved weight loss drug 2024

polskieradio.plOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Advancing Oral Delivery of Peptides and Complex Molecules

PharmTech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Doylestown’s Evrys Bio CEO Lillian Chiang Receives Timothy M. Block Biotech Impact Award

BioBuzzOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

fda approved weight loss drugs 2026 latest

www.polskieradio.plOriginal source
🇺🇸Industryyprime.comTier 1 · Company source

COG Europe 2026

YPrimeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc Unsponsored Brazilian Depositary Receipt Repr 0.0285714 Sh

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A New, Stronger GLP-1 Is Currently in Clinical Trials. Here's What Researchers Want You to Know

Women's HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day

MarketWatchOriginal source
🇺🇸Industrybiomarin.comTier 1 · Company source

RARE Scholars Charting New Paths in Medicine, Advocacy, Leadership and Business

BioMarin PharmaceuticalOriginal source
🇨🇦CROaltasciences.comTier 2 · Direct publisher

Biomarker Strategies to Enhance Early-Phase Drug Development

AltasciencesOriginal source
🌍discoverynews.google.comTier 2 · Trade media

FDA approves Cosette’s Evoxac oral solution for Sjögren’s disease

Pharmaceutical TechnologyOriginal source
🌍Industryexozymes.comTier 1 · Company source

CEO to discuss commercialization, key milestones, and potential catalysts in fireside chat with WTR

eXoZymesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

fda approves new weight-loss drug

BusinessWorld OnlineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

fda approved over-the-counter weight loss drugs 2026

BusinessWorld OnlineOriginal source